FDA approves new insulin inhaler for diabetics
See the original posting on The Verge
The US Food and Drug Administration today approved a new insulin inhaler for use in treating diabetes, its first in years. The product, which is made by California-based MannKind Corporation, uses a dry powder that people can breath in to control insulin levels. It’s been designed not as a full-time replacement to insulin injections, and instead as an alternative to them at meal times given the powder’s short-term effects that kick in within what the company says is between 12 to 15 minutes.